Evidence map›Paper›PMID 35932328›Full record

ReviewCellular and molecular life sciences : CMLS2022

Microbiota-assisted therapy for systemic inflammatory arthritis: advances and mechanistic insights.

Bowen Li, Bo Yang, Xiaoming Liu, Jianxin Zhao, R Paul Ross, Catherine Stanton, Hao Zhang, Wei Chen

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Psoriasis and gut microbiota: A Mendelian randomization study.Journal of cellular and molecular medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Bowen LiState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.ORCID http://orcid.org/0000-0002-4199-7164
Bo YangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China. bo.yang@jiangnan.edu.cn.ORCID http://orcid.org/0000-0002-1347-3718
Xiaoming LiuState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Jianxin ZhaoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
R Paul RossInternational Joint Research Center for Probiotics and Gut Health, Jiangnan University, Wuxi, Jiangsu, China. p.ross@ucc.ie.
Catherine StantonInternational Joint Research Center for Probiotics and Gut Health, Jiangnan University, Wuxi, Jiangsu, China.
Hao ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Wei ChenState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China. chenwei66@jiangnan.edu.cn.
Jiangnan University · CN

Funding

National Natural Science Foundation of China 31820103010National Natural Science Foundation of China 32021005
6 · The paper itself

Abstract

Research on the influence of gut microbiota on systemic inflammatory arthritis has exploded in the past decade. Gut microbiota changes may be a crucial regulatory component in systemic inflammatory arthritis. As a result of advancements in the field, microbiota-assisted therapy has evolved, but this discipline is still in its infancy. Consequently, we review the limitations of current systemic inflammatory arthritis treatment, analyze the connection between the microbiota and arthritis, and summarize the research progress of microbiota regulating systemic inflammatory arthritis and the further development aspects of microbiota-assisted therapy. Finally, the partial mechanisms of microbiota-assisted therapy of systemic inflammatory arthritis are being discussed. In general, this review summarizes the current progress, challenges, and prospects of microbiota-assisted therapy for systemic inflammatory arthritis and points out the direction for the development of microbiota-assisted therapy in the future.

Indexed as

Arthritis, PsoriaticGastrointestinal MicrobiomeMicrobiotaHumansAnkylosing spondylitisAssisted therapyMicrobiotaPsoriatic arthritisRheumatoid arthritisSystemic inflammatory arthritis

Identifiers

PMID35932328
PMCPMC11072763
OpenAlexW4290033619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.